Pexidartinib and Standard Neoadjuvant Therapy in the Adaptively Randomized I-SPY2 Trial for Early Breast Cancer
Breast Cancer Research and Treatment(2024)
Key words
Breast cancer,Clinical trial,Colony-stimulating factor-1,Pexidartinib
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined